Clinical Trials Search | Loyola Medicine

Study Title

A Phase II Study of LOXO-292 in Patients With RET Fusion-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)

Study Contact

NCTID

NCT04268550

Recruitment Status

ACTIVE_NOT_RECRUITING

Study Title

An Open Label Expanded Access Study of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies

Study Contact

NCTID

NCT04260698

Recruitment Status

ACTIVE_NOT_RECRUITING

Study Title

Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)

Study Contact

NCTID

NCT04267848

Recruitment Status

RECRUITING

Study Title

Recombinant tPA by Endovascular Administration for the Treatment of Submassive Pulmonary Embolism Using Pharmaco-mechanical Catheter Directed Thrombolysis for the redUction of Thrombus burdEn

Study Contact

NCTID

NCT04248868

Recruitment Status

COMPLETED

Study Title

AROMA Study: Anxiety Reduction During Office Procedural Medicine Using Aromatherapy

Study Contact

NCTID

NCT04260399

Recruitment Status

COMPLETED

Study Title

A Phase III Study of Consolidative Radiotherapy in Patients With Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA)

Study Contact

Nataliya V Uboha - Role: CONTACT - Phone: 608-265-9966 - Email: Nvuboha@medicine.wisc.edu

NCTID

NCT04248452

Recruitment Status

RECRUITING

Study Title

A Global Post Market Evaluation of Terumo Aortic Endovascular Grafts

Study Contact

Michelle Durnan - Role: CONTACT - Phone: +441418125555 - Email: m.durnan@terumoaortic.com
Sammy Dhaliwal - Role: CONTACT - Phone: +441418125555 - Email: s.dhaliwal@terumoaortic.com

NCTID

NCT04246463

Recruitment Status

RECRUITING

Study Title

Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events

Study Contact

David Kozono, MD, PhD - Role: CONTACT - Phone: 617-632-5734 - Email: dkozono@bwh.harvard.edu

NCTID

NCT04242095

Recruitment Status

RECRUITING

Study Title

Phase II Study of Bladder-SparIng ChemoradiatioN With Durvalumab in Clinical Stage III, Node PosItive BladdeR CancEr (INSPIRE)

Study Contact

NCTID

NCT04216290

Recruitment Status

ACTIVE_NOT_RECRUITING

Study Title

Dose Escalation Study of CD19 Chimeric Antigen Receptor (CAR) T Cells With a CD34 Selection Marker in Adults With Recurrent or Refractory B Cell Malignancies

Study Contact

NCTID

NCT04214886

Recruitment Status

ACTIVE_NOT_RECRUITING